Mammographic changes in postmenopausal women on Hormonal Replacement Therapy

European Radiology

Volumn 7, Issue 5, 1997, Pages 749-755

  Marugg, R C ^a,b   Van Der Mooren, M J ^a   Hendriks, J H C L ^a   Rolland, R ^a   Ruijs, S H J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Radiology   (Aruba)

Author keywords

Breast cancer screening; Breast, parenchymal pattern; Mammography; Oestrogen; Progestagen

Indexed keywords

AGED; ARTICLE; BREAST; BREAST TUMOR; COMPARATIVE STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PATHOLOGY; POSTMENOPAUSE; RADIOGRAPHY; RETROSPECTIVE STUDY; TIME;

AGED; BREAST; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; POSTMENOPAUSE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0030630596     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02742938     Document Type: Article

References (29)

1. Hammond CB, Maxson WS (1982) Current status of estrogen therapy for the menopause. Fertil Steril 37: 5
2. Ravnikar V (1990) Physiology and treatment of hot flushes. Obstet Gynecol 75 (Suppl): 3
3. Ettinger B (1988) Prevention of osteoporosis: treatment of estradiol deficiency. Obstet Gynecol 72: 12
4. Naesson T, Persson I, Adami HO, Bergström R, Bergkvist L (1990) Hormone replacement therapy and the risk for hip fracture. Ann Intern Med 113: 95
5. Stampfer MJ, Colditz GA (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assesment of the epidemiologic evidence. Prev Med 20: 47
6. Falkeborn M, Persson I, Adami HO, Bergstrom R, Eaker E, Lithell H, Mohsen R, Naessen T (1992) The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 99: 821
7. Creasy GW, Kafrissen ME, Upmalis D (1992) Review of the endometrial effects of estrogens and progestins. Obstet Gynecol Surv 47: 654
8. Kaufman Z, Garstin WIH, Hayes R, Michell MJ, Baum M (1991) The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 43: 389
9. Buchanan JB, Weisberg BF, Sandoz JP, Gray LA, Bland KI (1981) Selected prognostic variables for mammographic parenchymal patterns. Cancer 47: 2135
10. Waard F de, Rombach JJ, Collette HJA, Slotboom B (1984) Breast cancer risk associated with reproductive factors and breast parenchymal patterns. J Natl Cancer Inst 72: 1277
11. Verbeek ALM, Hendriks JHCL, Peeters PHM, Sturmans F (1984) Mammographic breast pattern and the risk of breast cancer. Lancet 1: 591
12. Leinster SJ, Walsh PV, Whitehouse GH, Al-Sumidaie AM (1988) Factors associated with mammographic parenchymal patterns. Clin Radiol 39: 252
13. Van der Mooren MJ, Demacker PNM, Thomas CMG, Borm GF, Rolland R (1993) A 2-year study on the beneficial effects of 17ß-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone. Eur J Obstet Gynecol Reprod Biol 52: 117
14. Van der Mooren MJ, Gevers Leuven JA, Rolland R (1994) Effeet of conjugated estrogen with and without medrogestone: a prospective study. Maturitas 19: 33
15. Wolfe JN (1976) Breast patterns as an index of risk for developing breast cancer. AJR 126: 1130
16. Peyster RG, Kalisher L, Cole PH (1977) Mammographic parenchymal patterns and the prevalence of breast cancer. Radiology 125: 387
17. Tabár L, Dean PB (1982) Mammographic parenchymal patterns, risk indicator for breast cancer? J Am Med Assoc 247: 185
18. Berkowitz JE, Gatewood OMB, Goldblum LE, Gayler BW (1990) Hormonal replacement therapy: mammographic manifestations. Radiology 174: 199
19. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE (1990) Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 174: 487
20. Cyrlak D, Wong CH (1993) Mammographic changes in post-menopausal women undergoing hormonal replacement therapy. AJR 161: 1177
21. Kuttenn F, Fournier S, Sitruk-Ware R, Martin P, Mauvais-Jarvis P (1983) Progesterone deficiency in benign breast disease. In: Angeli A, Bradlow ML, Dogliotti L (ed) Endocrinology of cystic breast disease. Raven Press, New York, pp 231-252
22. Key TJA, Pike MC (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29
23. Wingo PA, Layde PM, Lee NC, Rubin G, Ory HW (1987) The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. J Am Med Assoc 257: 209
24. Gambrell RD Jr (1984) Proposal to decrease the risk and improve the prognosis of breast cancer. Am J Obstet Gynecol 150: 119
25. Hunt K, Vessey M, McPherson K, Coleman M (1987) Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 94: 620
26. Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C (1989) The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321: 293
27. Dupont WD, Page DL (1991) Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 151: 67
28. Henderson IC (1993) Risk factors for breast cancer development. Cancer 71 (Suppl): 2127
29. Tabár L, Faberberg G, Day NE, Holmberg L (1987) What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 55: 547